Pull 4 Parkinson’s Foundation, Inc., a registered 501(c)(3) public charity,
funds cure and care research conducted by the Parkinson's disease community.
Learn More or Donate.

39 Parkinson’s Trials Are Withdrawn

Trial Name Last Updated
Deep Brain Stimulation for Refractory Alcoholism 04/26/2018
Mitochondrial Dysfunction in the Pathophysiology and Treatment of Bipolar Disorder 04/26/2018
Treating Sleep/Wake Cycle Disturbances in Basal Ganglia Disorders With Ramelteon 04/26/2018
Dexmedetomidine Effects on Microelectrode Recording in Deep Brain Stimulation 04/26/2018
Nurse Management of Neuromodulation Therapy 04/26/2018
Inpatient Physical Activity Function Through Enhanced Participation Levels in Animal-Assisted Therapy Programs 04/26/2018
Study Assessing Tolerability and Safety and Exploring the Immunogenicity and Therapeutic Activity of AFFITOPE® PD01A in PD-GBA Patients 04/26/2018
Optimizing DBS Electrode Placement and Programming 04/26/2018
BIIB014 Phase 2a Monotherapy 04/26/2018
Concurrent DBS Local Field Potential Analysis and Stimulation in a Closed-Loop Neuromodulation Device 04/26/2018
The Essential Tremor (ET) and Parkinson Disease (PD) Tremor Acute Stimulation Study 04/26/2018
A Cross-Over, Multi-Center Trial to Evaluate the Diagnostic Efficacy and Safety of [123I]NAV5001 as an Imaging Agent to Aid in the Diagnosis of Parkinsonian Syndromes 04/26/2018
The Safety of Remote DBS Programming System 04/26/2018
Natural History of Levodopa-Induced Dyskinesia (LID) 04/26/2018
Electrophysiological Investigation and rTMS Intervention of Ambulatory Central Processing of Freezing of Gait in Parkinson's Disease 04/26/2018
Study to Assess Droxidopa in the Treatment of Freezing Of Gait Symptoms in Patients With Parkinson's Disease 04/26/2018
Gastric Retentive Carbidopa/ Levodopa in Parkinson's Patients; a One Year, Open Label, Safety Extension Study 04/26/2018
Keppra IV for the Treatment of Motor Fluctuations in Parkinson's Disease 04/26/2018
Feasibility Study to Evaluate Deep Brain Stimulation (DBS) Settings for the Treatment of Parkinson's Disease 04/26/2018
Carbidopa/Levodopa Versus Carbidopa/Levodopa/Entacapone on Markers of Event Related Potentials (ERPs) in Patients With Idiopathic Parkinson's Disease (PD) and End-of-dose Wearing Off 04/26/2018
Incobotulinum Toxin A for Sialorrhea in Parkinson's Disease (PD)/Parkinsonism and Amyotrophic Lateral Sclerosis (ALS) 04/26/2018
A Multidisciplinary Approach to Manage Gait Difficulty in Parkinson Patients 04/26/2018

Page 1 of 2 pages  1 2 > 

All ClinicalTrials.gov articles provided courtesy of National Library of Medicine (NLM).